InvestorsHub Logo
Post# of 4972916
Next 10
Followers 5
Posts 2568
Boards Moderated 0
Alias Born 11/03/2019

Re: None

Monday, 05/23/2022 12:57:18 PM

Monday, May 23, 2022 12:57:18 PM

Post# of 4972916
$ATRX MLR-1019 (armesocarb) is a new class of drug for Parkinson's Disease (PD) and represents the only drug to address both movement and non-movement symptoms of PD. Armesocarb is the active enantiomer in mesocarb, a drug marketed in Europe for 37 years for various psychiatric and central nervous system indications.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.